Dr Barker has performed hematopoietic stem cell transplantation for over 25 years. She is currently the Director of the Bone Marrow Transplant and Cell Therapy Program at Weill Cornell Medicine/NewYork-Presbyterian (WCM/NYP). As Program Director, her aim is to extend access to state-of-the-art transplantation and cell therapy to all patients including the under-served, and conduct or facilitate research spanning bench-to-bedside clinical translation of novel therapies to strategies to improve the delivery of complex cancer care to under-served groups including the elderly or those with diagnoses previously considered ineligible for treatment. She also has an ongoing career interest in the mentorship of trainees, faculty and other health care professionals. Her own research has investigated strategies to extend allogeneic transplantation to racial/ ethnic minorities and other underserved patients using alternative stem cell sources with a special focus on neonatal cord blood (CB). Dr Barker has pioneered multiple approaches that have under-scored modern CB transplantation. Her work has highlighted the need to study access of diverse ancestral groups to curative allogeneic transplantation. Having previously acted as an advisor to the National Marrow Donor Program and a member of the U.S. government HRSA Advisory Council on Blood Stem Cell Transplantation, she now Chairs the National Cord Blood Network consortium.